These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 104988)
21. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase. Sato F; Nagasawa S Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. Kleniewski J; Blankenship DT; Cardin AD; Donaldson V J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355 [TBL] [Abstract][Full Text] [Related]
23. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
24. Characterization of human high molecular weight kininogen. Procoagulant activity associated with the light chain of kinin-free high molecular weight kininogen. Thompson RE; Mandle R; Kaplan AP J Exp Med; 1978 Feb; 147(2):488-99. PubMed ID: 75240 [TBL] [Abstract][Full Text] [Related]
25. Purification of high molecular weight kininogen and the role of this agent in blood coagulation. Saito H J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664 [TBL] [Abstract][Full Text] [Related]
26. Mapping of functional domains of human high molecular weight and low molecular weight kininogens using murine monoclonal antibodies. Ishiguro H; Higashiyama S; Ohkubo I; Sasaki M Biochemistry; 1987 Nov; 26(22):7021-9. PubMed ID: 2447941 [TBL] [Abstract][Full Text] [Related]
27. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. Kerbiriou DM; Bouma BN; Griffin JH J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706 [TBL] [Abstract][Full Text] [Related]
28. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein. Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899 [TBL] [Abstract][Full Text] [Related]
29. Occurrence of Leu-Lys-bradykinin and histidine-rich peptide in high-molecular-weight kininogen isolated from horse plasma. Sugo T; Kato H; Iwanaga S; Fujii S Biochim Biophys Acta; 1979 Aug; 579(2):474-8. PubMed ID: 534657 [TBL] [Abstract][Full Text] [Related]
30. [Single-chain, low molecular weight kininogen in the blood plasma of rabbits: isolation and fragmentation by porcine pancreatic kallikrein]. Levina GO; Makevnina LG; Sherstiuk SF; Paskhina TS Biokhimiia; 1985 Feb; 50(2):325-36. PubMed ID: 3845817 [TBL] [Abstract][Full Text] [Related]
31. Purification of human low molecular weight kininogen and its application for a simple ND sensitive method for determination of human urinary kallikrein activity. Nakagawa M; Shimamoto K; Kondo M; Ura N; Nishitani T; Ishida H; Yokoyama T; Tanaka S; Iimura O Adv Exp Med Biol; 1986; 198 Pt B():523-9. PubMed ID: 3643739 [TBL] [Abstract][Full Text] [Related]
32. Hydrolysis of human high-molecular-mass kininogen by human plasma kallikrein. Proposal of a new model concept for the course of reaction in presence and absence of C1(-)-inhibitor. Wiedler J; Dutler H Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1203-13. PubMed ID: 3675872 [TBL] [Abstract][Full Text] [Related]
33. Primary structures of guinea pig high- and low-molecular-weight kininogens. Semba U; Umeda Y; Shibuya Y; Okabe H; Tanase S; Yamamoto T Int Immunopharmacol; 2004 Oct; 4(10-11):1391-400. PubMed ID: 15313436 [TBL] [Abstract][Full Text] [Related]
34. Structural aspects of human kininogens. Muller-Esterl W; Dittmann B; Fritz H; Lottspeich F; Henschen A Adv Exp Med Biol; 1983; 156():157-64. PubMed ID: 6552837 [TBL] [Abstract][Full Text] [Related]
35. Porcine high molecular weight kininogen: its purification and properties as a thiol proteinase inhibitor as compared to human high molecular weight kininogen. Tani Y; Ohkubo I; Higashiyama S; Kunimatsu M; Sasaki M Comp Biochem Physiol B; 1987; 88(2):429-41. PubMed ID: 3123124 [TBL] [Abstract][Full Text] [Related]
36. Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat. Hayashi I; Ino T; Kato H; Iwanaga S; Nakano T; Oh-ishi S Thromb Res; 1984 Dec; 36(6):509-16. PubMed ID: 6570369 [TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of alpha 1-thiol proteinase inhibitor and its identity with kinin- and fragment 1.2-free high molecular weight kininogen. Ohkubo I; Namikawa C; Higashiyama S; Sasaki M; Minowa O; Mizuno Y; Shiokawa H Int J Biochem; 1988; 20(3):243-58. PubMed ID: 3356290 [TBL] [Abstract][Full Text] [Related]
38. Purification and characterization of two kinds of low molecular weight kininogens from rat (non-inflamed) plasma. One resistant and the second sensitive to rat glandular kallikreins. Enjyoji K; Kato H; Hayashi I; Oh-ishi S; Iwanaga S J Biol Chem; 1988 Jan; 263(2):965-72. PubMed ID: 3335530 [TBL] [Abstract][Full Text] [Related]
39. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed. Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701 [TBL] [Abstract][Full Text] [Related]
40. Further characterization of monoclonal antibodies against rat plasma kallikrein, rat low molecular weight kininogen and synthetic bradykinin. Bedi GS; Back N Adv Exp Med Biol; 1989; 247B():223-30. PubMed ID: 2610064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]